drugset

drugset / Trial / NCT01697410

Continuos Terlipressin Infusion in Septic Shock

NCT01697410 ↗

Unknown 1000 enrolled First Affiliated Hospital, Sun Yat-Sen University Anhui Provincial Hospital · collab Beijing 302 Hospital · collab China Medical University, China · collab Chinese PLA General Hospital · collab First People's Hospital of Foshan · collab Guangdong Province, Department of Science and Technology · collab Guangxi Medical University · collab Hainan People's Hospital · collab Jinling Hospital, China · collab Second Affiliated Hospital, Sun Yat-Sen University · collab Shanghai Changzheng Hospital · collab Sixth Affiliated Hospital, Sun Yat-sen University · collab The First Affiliated Hospital of Bengbu Medical University · collab Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · collab West China Hospital · collab Xi'an Jiaotong University · collab Xiangya Hospital of Central South University · collab ZhuHai Hospital · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy of terlipressin for treating septic shock.

Timeline

Start: 2013-01
Primary completion: 2016-01
Completion: 2016-01

Publications

Liu ZM, Chen J, Kou Q, Lin Q, Huang X, Tang Z, Kang Y, Li K, Zhou L, Song Q, Sun T, Zhao L, Wang X, He X, Wang C, Wu B, Lin J, Yuan S, Gu Q, Qian K, Shi X, Feng Y, Lin A, He X; Study Group of investigators; Guan XD. Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial. Intensive Care Med. 2018 Nov;44(11):1816-1825. doi: 10.1007/s00134-018-5267-9. Epub 2018 Jul 3.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Norepinephrine	Other / unclassified	7.5 ug	Other
Comparator	Norepinephrine	Other / unclassified	30 ug	Other
Subject	Terlipressin	Peptide	0.66 ug	Other
Subject	Terlipressin	Peptide	2.66 ug	Other

Indications